Christopher M. Blanchette, PhD
Articles
January 24th 2011
Relationship Between Short-Acting β-Adrenergic Agonist Use and Healthcare Costs
Harris S. Silver, MD Christopher M. Blanchette, PhD Shital Kamble, PhD Hans Petersen, MS Matthew A. Letter, BS David Meddis, PhD Benjamin Gutierrez, PhD
Overuse of rescue medication among asthma patients is associated with increased exacerbations and higher total and asthma-related healthcare costs.
July 15th 2008
Economic Assessment of Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease
Manabu Akazawa, PhD D. Cortney Hayflinger, MS Richard H. Stanford, PharmD Christopher M. Blanchette, PhD
Compared with ipratropium alone, fluticasone/salmeterol combination therapy resulted in better clinical outcomes and similar or lower treatment costs in all COPD populations studied.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: November 21st 2024 | Updated: November 23rd 2024
Polygenic Risk Scores Can Identify Patients Who Should Receive IOP-Lowering Treatment
